Hyperactivity News and Research

RSS

Huntington's disease monkey model embodies full array of symptoms similar to human patients

Transgenic Huntington's disease monkeys display a full spectrum of symptoms resembling the human disease, ranging from motor problems and neurodegeneration to emotional dysregulation and immune system changes, scientists at Yerkes National Primate Research Center, Emory University report.

21 Jul 2016

Novel method of mindfulness meditation can improve emotional and cognitive performance

Meditation has long been promoted as a way to feel more at peace. But research from a Texas Tech University faculty member shows it can significantly improve attention, working memory, creativity, immune function, emotional regulation, self-control, cognitive and school performance and healthy habits while reducing stress.

18 Jul 2016

Early attention problems in children can have lasting impact on academic outcomes

Children with attention problems in early childhood were 40 percent less likely to graduate from high school, says a new study from Duke University that examines how early childhood characteristics affect academic performance.

7 Jul 2016

Existing anti-inflammatory drugs may be effective in treating epilepsy

In epileptic patients, seizures lead to an increased level of inflammation-related proteins called chemokines in the brain, and systemic inflammation likely helps trigger and promote the recurrence of seizures, making inflammation a promising new target for anticonvulsant therapy.

6 Jul 2016

Environmental toxins affect children's brain development, experts agree

An unprecedented alliance of leading scientists, health professionals, and children's and environmental health advocates agree for the first time that today's scientific evidence supports a link between exposures to toxic chemicals in air, water, food and everyday products and children's risks for neurodevelopmental disorders.

4 Jul 2016

Paracetamol use during pregnancy linked to hyperactivity, autism spectrum symptoms in children

A new study has found that paracetamol (acetaminophen), which is used extensively during pregnancy, has a strong association with autism spectrum symptoms in boys and for both genders in relation to attention-related and hyperactivity symptoms.

1 Jul 2016

Neurotherapeutic video game may help improve cognitive abilities in children with genetic disorders

A UC Davis researcher has created a video game for children who experience cognitive impairments from genetic disorders with the hope that that it will improve their ability to mentally process information about space and time.

23 Jun 2016

Diabetic mothers three times more likely to have anti-fetal brain autoantibodies

Mothers of children with autism and were diagnosed with metabolic conditions during pregnancy, particularly gestational and type 2 diabetes, were more likely to have anti-fetal brain autoantibodies in their blood compared to healthy women of children with autism.

20 Jun 2016

Exercise can help improve ADHD symptoms in adults

Exercise, even a small amount, can help alleviate symptoms of ADHD in adults, according to a new study by University of Georgia researchers.

17 Jun 2016

Shire introduces third annual Excellence in ADHD Patient Group Awards

Shire plc today launches the third annual Excellence in ADHD Patient Group Awards celebrating outstanding work by patient advocacy organisations around the world that aim to improve the lives of people with Attention Deficit/Hyperactivity Disorder (ADHD).

17 Jun 2016

U-M study compares early-use and longer-duration stimulant medication with nonstimulant therapy for ADHD

Youth who take Ritalin, Adderall or other stimulant medications for ADHD over an extended period of time early in life are no more at risk for substance abuse in later adolescence than teens without ADHD, according to a University of Michigan study.

9 Jun 2016

Children in foster care still face quality challenges in antipsychotic medication use

Significant quality challenges persist in antipsychotic medication use for children in foster care and other Medicaid-insured children, according to a new Rutgers University-New Brunswick study published in Health Affairs.

8 Jun 2016

Maternal immune dysfunction linked to risk of autism with intellectual disability in children

Pregnant women with higher levels of inflammatory cytokines and chemokines, proteins that control communication between cells of the immune system, may be at significantly greater risk of having a child with autism combined with intellectual disability, researchers with the UC Davis MIND Institute have found.

8 Jun 2016

Children with ADHD experience difficulties in adapting behaviour to given situations

Children with Attention Deficit Hyperactivity Disorder (ADHD) often display behaviours that are inappropriate for the situation in which they are in. They might move around in the classroom during a lesson, or talk non-stop and interrupt others' conversations.

4 Jun 2016

Majority youths with autism or intellectual disability receive antipsychotics, study finds

About one in ten youths treated with an antipsychotic are diagnosed with autism spectrum disorder or intellectual disability. Conversely, one in six youths diagnosed with autism spectrum disorder has been prescribed antipsychotics.

31 May 2016

Early exposure to nicotine can affect formation of connections between brain cells long after birth

Early exposure to nicotine can trigger widespread genetic changes that affect formation of connections between brain cells long after birth, a new Yale-led study has found. The finding helps explains why maternal smoking has been linked to behavioral changes such as attention deficit and hyperactivity disorder, addiction and conduct disorder.

30 May 2016

Study assesses trends in antidepressant prescribing for depression

In a study appearing in the May 24/31 issue of JAMA, Jenna Wong, M.Sc., of McGill University, Montreal, Canada, and colleagues analyzed treatment indications for antidepressants and assessed trends in antidepressant prescribing for depression.

25 May 2016

Neos announces U.S. launch of Adzenys XR-ODT for ADHD

Neos Therapeutics, Inc., a pharmaceutical company with a late‐stage pipeline of innovative extended-release (XR) product candidates for the treatment of attention-deficit/hyperactivity disorder (ADHD), today announced that Adzenys XR-ODT™ is in distribution channels and is now available to prescribe for patients with ADHD in the United States.

16 May 2016

University of Derby introduces new MOOC to provide better knowledge on autism, Asperger’s and ADHD

A new Massive Open Online Course (MOOC) to educate anyone interested in learning more about autism, Asperger’s and Attention-Deficit/Hyperactivity Disorder (ADHD) has been launched by the University of Derby.

From University of Derby Online Learning 13 May 2016

Researchers agree to test new stem cell gene therapy for Sanfilippo disease in human trial

Scientists in Manchester, who have developed a stem cell gene therapy to reverse a fatal childhood illness, have agreed to work with a new therapeutics company to test it in a human trial.

11 May 2016